JournalsHub
.online
Find My Journal
JA

Jane E. Ambler

ContraFect (United States) US

36
Publications
1,709
Citations
14
H-Index
17
i10-Index
40.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests OA
Romney M. Humphries, Jane E. Ambler, Stephanie L. Mitchell, Mariana Castanheira, Tanis C. Dingle +13 more
Journal of Clinical Microbiology 2018
728
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae OA
Xiao-Su Pan, Jane E. Ambler, Shaheen Mehtar, L. Mark Fisher
Antimicrobial Agents and Chemotherapy 1996
437
Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro OA
Victoria J. Heaton, Jane E. Ambler, L. Mark Fisher
Antimicrobial Agents and Chemotherapy 2000
82
Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland
Colin E. Goldsmith, John E. Moore, Philip G. Murphy, Jane E. Ambler
Journal of Antimicrobial Chemotherapy 1998
59
Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for<i>Staphylococcus aureus</i>: the role of PBP2a in the activity of ceftaroline OA
Sushmita D. Lahiri, Robert E. McLaughlin, James Whiteaker, Jane E. Ambler, Richard A. Alm
Journal of Antimicrobial Chemotherapy 2015
45

Publications

36 total

Exebacase in Addition to Standard-of-Care Antibiotics for <i>Staphylococcus aureus</i> Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT) PDF

Vance G. Fowler, Anita Das, Joy Lipka-Diamond, Jane E. Ambler, Raymond Schuch et al. - Clinical Infectious Diseases, 2024
Cited by 40 OpenAlex

Erratum for Humphries et al., “CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests” PDF

Romney M. Humphries, Jane E. Ambler, Stephanie L. Mitchell, Mariana Castanheira, Tanis C. Dingle et al. - Journal of Clinical Microbiology, 2023
Cited by 20 OpenAlex

Rapid bacteriolysis of <i>Staphylococcus aureus</i> by lysin exebacase PDF

Xavier Vila‐Farrés, Karen Sauve, Jun Kyun Oh, Steven M. Swift, Boudewijn L DeJonge et al. - Microbiology Spectrum, 2023
Cited by 13 OpenAlex

Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity PDF

Maria M. Traczewski, Jane E. Ambler, Raymond Schuch - Journal of Clinical Microbiology, 2021
Cited by 16 OpenAlex

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests PDF

Romney M. Humphries, Jane E. Ambler, Stephanie L. Mitchell, Mariana Castanheira, Tanis C. Dingle et al. - Journal of Clinical Microbiology, 2018
Cited by 728 OpenAlex

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model PDF

Renu Singh, Mashal M. Almutairi, Richard A. Alm, Sushmita D. Lahiri, Maryann San Martin et al. - Journal of Antimicrobial Chemotherapy, 2017
Cited by 24 OpenAlex

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for<i>Staphylococcus aureus</i>: the role of PBP2a in the activity of ceftaroline PDF

Sushmita D. Lahiri, Robert E. McLaughlin, James Whiteaker, Jane E. Ambler, Richard A. Alm - Journal of Antimicrobial Chemotherapy, 2015
Cited by 45 OpenAlex

<i>In Vitro</i> Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program PDF

Douglas J. Biedenbach, Richard A. Alm, Sushmita D. Lahiri, E Reiszner, Daryl J. Hoban et al. - Antimicrobial Agents and Chemotherapy, 2015
Cited by 42 OpenAlex

<i>In Vitro</i> Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program PDF

Douglas J. Biedenbach, Daryl J. Hoban, E Reiszner, Sushmita D. Lahiri, Richard A. Alm et al. - Antimicrobial Agents and Chemotherapy, 2015
Cited by 15 OpenAlex

Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia

Charles Fogarty, Antoni Torres, Shurjeel Choudhri, Daniel Haverstock, Janet Herrington et al. - International Journal of Clinical Practice, 2005
Cited by 18 OpenAlex

Research Topics

Antibiotics Pharmacokinetics and Efficacy (18) Antibiotic Resistance in Bacteria (16) Antimicrobial Resistance in Staphylococcus (15) Bacterial Identification and Susceptibility Testing (9) Pneumonia and Respiratory Infections (5)

Frequent Co-Authors

SU
Sushmita D. Lahiri
4 joint publications
RI
Richard A. Alm
4 joint publications
RO
Romney M. Humphries
3 joint publications
TA
Tanis C. Dingle
3 joint publications
LA
Laura Koeth
3 joint publications
KA
Katherine Sei
3 joint publications

Affiliations

AstraZeneca (United Kingdom)
GB 2014 - 2014
University of London
GB 1996 - 1993
St George's Hospital
GB 1996 - 1996
Bayer (United States)
US 2008 - 2005
Wockhardt (United States)
US 2018 - 2016

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now